Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

NCT06648850 is registered in ClinicalTrials.gov with Applied Biology, Inc. as lead sponsor.

NCT NCT06648850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06648850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth
Lead sponsor
Applied Biology, Inc.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
April 26, 2027
Enrollment
1,120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia, androgenetic alopecia (aga), female pattern hair loss, female pattern hair loss, androgenic alopecia, male pattern baldness, telogen effluvium